Molecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal; Faculty of Medicine of the University of Porto (FMUP), 4200-319, Porto, Portugal; Research Department of the Portuguese League Against Cancer-Regional Nucleus of the North (Liga Portuguesa Contra o Cancro-Núcleo Regional do Norte), 4200-177, Porto, Portugal.
Molecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal; Faculty of Medicine of the University of Porto (FMUP), 4200-319, Porto, Portugal.
Crit Rev Oncol Hematol. 2021 May;161:103310. doi: 10.1016/j.critrevonc.2021.103310. Epub 2021 Mar 27.
High-risk human papillomavirus (HPV) is the most frequent sexually transmitted agent worldwide and is responsible for approximately 5% of human cancers. Identifying novel biomarkers and therapeutic targets for these malignancies requires a deeper understanding of the mechanisms involved in the progression of HPV-induced cancers. Long non-coding RNAs (lncRNAs) are crucial in the regulation of biological processes. Importantly, these molecules are key players in the progression of multiple malignancies and are able to regulate the development of the different hallmarks of cancer. This review highlights the action of lncRNAs in the regulation of cellular processes leading to the typical hallmarks of cancer. The regulation of lncRNAs by HPV oncogenes, their targets and also their mechanisms of action are also discussed, in the context of HPV-induced malignancies. Overall, accumulating data indicates that lncRNAs may have a significant potential to become useful tools for clinical practice as disease biomarkers or therapy targets.
高危型人乳头瘤病毒(HPV)是全球最常见的性传播病原体,约占人类癌症的 5%。为这些恶性肿瘤确定新的生物标志物和治疗靶点需要深入了解 HPV 诱导的癌症进展过程中的机制。长链非编码 RNA(lncRNA)在调节生物过程中至关重要。重要的是,这些分子是多种恶性肿瘤进展的关键参与者,能够调节癌症不同特征的发展。这篇综述强调了 lncRNA 在调节导致典型癌症特征的细胞过程中的作用。还讨论了 HPV 致癌基因、它们的靶标以及它们在 HPV 诱导的恶性肿瘤中的作用机制对 lncRNA 的调节。总的来说,越来越多的数据表明,lncRNA 可能具有很大的潜力成为临床实践中疾病生物标志物或治疗靶点的有用工具。